Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Association of Hematocrit and Platelet Values Post RBC Exchange (RCE) with Vaso-Occlusive Complications in Sickle Cell Disease (SCD)

Insia Rizvi, Victor R. Gordeuk, Xu Zhang, Robert Molokie, David Allison, Sally Campbell Lee, Marwah Farooqui

Blood (2024) 144 (Supplement 1): 5363.

https://doi.org/10.1182/blood-2024-206189

Published: 2024

Journal Articles

Understanding the Menopause Transition in Sickle Cell Disease: An Interim Analysis of the Implementation of the Adapted Menopause Transition Questionnaire

Marwah Farooqui, Insia Rizvi, Lewis L Hsu, Santosh L. Saraf, Jin Han, Taif Hassan, Robert Molokie, Franklin Njoku, Gelila Goba

Blood (2024) 144 (Supplement 1): 5066.

https://doi.org/10.1182/blood-2024-209689

Published: 2024

Journal Articles

Effect of the Oral LSD1 Inhibitor Ory-1001 on F-Retics in Baboons ( Papio anubis )

Vinzon Ibanez, Kestis Vaitkus, Robert Molokie, Yogenthiran Saunthararajah, Donald Lavelle

Blood (2023) 142 (Supplement 1): 1109.

https://doi.org/10.1182/blood-2023-189523

Published: 2023

Journal Articles

Translating an HPFH-Mechanism into Oral Small Molecule Therapy for Beta-Hemoglobinopathies: Clinical Proof-of-Principle

Robert Molokie, Santosh L. Saraf, Lani Krauz, Michael Pacini, David Chan, Alana Aziz-Bradley, Rebeca Gansari, Taif Hassan, Philip Woost, James Jacobberger, Victor R. Gordeuk, Donald E. Lavelle, Joseph DeSimone, Yogenthiran Saunthararajah

Blood (2023) 142 (Supplement 1): 2524.

https://doi.org/10.1182/blood-2023-186228

Published: 2023

Journal Articles

Β-Lactam Antibiotic Ceftriaxone As a Potential Therapeutic Intervention for Chronic Pain in Sickle Cell Disease

Ying He, Xiao Guo, Robert Molokie, Zaijie Jim Wang

Blood (2023) 142 (Supplement 1): 2495.

https://doi.org/10.1182/blood-2023-188342

Published: 2023

Journal Articles

Iron Overload and Treatment Outcome in an Adult Sickle Cell Disease Cohort

Franklin Njoku, Marwah Farooqui, Insia Rizvi, Jin Han, Robert Molokie, Santosh L. Saraf, Victor R. Gordeuk

Blood (2023) 142 (Supplement 1): 5331.

https://doi.org/10.1182/blood-2023-190229

Published: 2023

Journal Articles

Fruit and Vegetable Intake in Adults with Sickle Cell Disease

Syeda Akila Ally, Jin Han, Robert Molokie, Maria Armila Ruiz, Victor R. Gordeuk, James Lash, Santosh L. Saraf

Blood (2023) 142 (Supplement 1): 5301.

https://doi.org/10.1182/blood-2023-180756

Published: 2023

Journal Articles

A Pilot Study for the Kidney Effects of Voxelotor in Sickle Cell Anemia

Santosh L. Saraf, Lani Krauz, Robert Molokie, Franklin Njoku, Maria Armila Ruiz, Guadalupe Salas, Alana Aziz-Bradley, Jin Han, Victor R. Gordeuk

Blood (2023) 142 (Supplement 1): 5296.

https://doi.org/10.1182/blood-2023-178630

Published: 2023

Journal Articles

Biomarker Association with Hypertension in Mild Versus Severe Sickle Cell Disease Genotypes of a Single Center Cohort, in Comparison with African Americans from the Nhanes Study

Franklin Njoku, Xu Zhang, Binal N. Shah, Faiz Ahmed Hussain, Jin Han, Robert Molokie, Roberto Machado, Santosh L. Saraf, Victor R. Gordeuk

Blood (2021) 138 (Supplement 1): 2051.

https://doi.org/10.1182/blood-2021-152573

Published: 2021

Journal Articles

Vaso-Occlusive Events Precipitated By Intraarticular Steroid Injections in Patients with Sickle Cell Disease

Landan Banks, Michel Gowhari, DO, Robert Molokie, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-142900

Published: 2020

Journal Articles

Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons

Vinzon Ibanez, Kestis Vaitkus, Angela Rivers, Robert Molokie, Shuaiying Cui, James Douglas Engel, Joseph DeSimone, Donald Lavelle

Blood (2017) 129 (2): 260–263.

https://doi.org/10.1182/blood-2016-10-746727

Published: 2017

Journal Articles

Clinical Efficacy and Safety of Erythroid Stimulating Agents in Sickle Cell Disease

Santosh Saraf, MD, Robert Molokie, MD, Michel Gowhari, DO, Johara Hassan, MD, Victor R. Gordeuk, MD

Blood (2012) 120 (21): 3218.

https://doi.org/10.1182/blood.V120.21.3218.3218

Published: 2012

Journal Articles

A Case Series: Chiari Malformation and Sickle Cell Disease

Michel Gowhari, DO, Robert Molokie, MD, Fernando Testai, MD, Victor R. Gordeuk, MD, Olaide I. Ajayi, MBBS

Blood (2012) 120 (21): 4772.

https://doi.org/10.1182/blood.V120.21.4772.4772

Published: 2012

Journal Articles

Pain Medication: Time to First Dose in Sickle Cell Acute Care in Two Settings of a Large Urban Hospital

Bonnye Johnson, MS, RN, Dawn Lei, BS, Nicholas F Furtado, MD, Saman K. Hashmi, MD, Robert Molokie, MD, Joseph DeSimone, PhD, Johara Hassan, MD, Michel Gowhari, DO, Tara Gordon, RN, Darcel Dowell, RN, Glenda Pendarvis, RN, Heather Prendergast, MD, Victor R. Gordeuk, MD, Lewis L. Hsu, MD, PhD

Blood (2012) 120 (21): 4693.

https://doi.org/10.1182/blood.V120.21.4693.4693

Published: 2012

Journal Articles

Clinical and Laboratory Predictors for Renal Damage in Sickle Cell Disease

Santosh L Saraf, MD, Robert Molokie, MD, Johara Hassan, MD, Michel Gowhari, DO, James Lash, MD, Victor R. Gordeuk, MD

Blood (2012) 120 (21): 3252.

https://doi.org/10.1182/blood.V120.21.3252.3252

Published: 2012

Journal Articles

A Comparison of Two Pain Assessment Tools, the Adolescent Pediatric Pain Tool and PAINReportIt and Use of the Composite Pain Index in Sickle Cell Disease

A. Kyle Mack, MD, Stephanie Pelligra, BS, MPH, Richard J. Labotka, MD, MS, Robert Molokie, MD, Young O Kim, PhD, RN, Alexis Thompson, MD, MPH, Diana J Wilkie, PhD, RN

Blood (2010) 116 (21): 2648.

https://doi.org/10.1182/blood.V116.21.2648.2648

Published: 2010

Journal Articles

Fever In Hospitalized Adult Patients with Sickle Cell Disease

Deepa Jeyakumar, MD, Matthew Zibelman, MD, Ryan Hurth, MD, Lani Krauz, RN, Santosh Saraf, MD, Robert Molokie, MD, Joseph DeSimone, PhD

Blood (2010) 116 (21): 2652.

https://doi.org/10.1182/blood.V116.21.2652.2652

Published: 2010

Journal Articles

Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes

Carlton Dampier, MD, Wally R. Smith, MD, Carrie Wager, Margaret Bell, James R. Eckman, MD, Lewis L Hsu, MD, PhD, Donna McClish, PhD, Sonja McKinlay, PhD, Caterina Minitti, MD, Robert Molokie, MD, Kim Smith-Whitley, MD, Marilyn J. Telen, MD, Debra Weiner, MD, PhD, Scott Miller, MD

Blood (2010) 116 (21): 2667.

https://doi.org/10.1182/blood.V116.21.2667.2667

Published: 2010

Journal Articles

Significance of, and Difficulty in Diagnosing, Erythropoietin Deficiency in Sickle Cell Anemia

Santosh L Saraf, MD, Seema Sidhwani, DO, Mohammed Farooqui, DO, Giovanni Infusino, MD, Lani Krauz, RN, Michael Gowhari, MD, Stephen Vara, MD, Louise Dorn, RN, MS, Joseph Desimone, PhD, Robert Molokie, MD, Yogen Saunthararajah, MD

Blood (2008) 112 (11): 2479.

https://doi.org/10.1182/blood.V112.11.2479.2479

Published: 2008

Journal Articles

Usual Clinical Parameters Underestimate the Incidence and Significance of Erythropoietin Deficiency as a Risk Factor for Death in Sickle Cell Disease.

Santosh Saraf, Seema Sidhwani, Mohammed Farooqui, Stephen Vara, Joseph DeSimone, Robert Molokie, Yogenthiran Saunthararajah

Blood (2007) 110 (11): 3791.

https://doi.org/10.1182/blood.V110.11.3791.3791

Published: 2007

NARROW

Association of Hematocrit and Platelet Values Post RBC Exchange (RCE) with Vaso-Occlusive Complications in Sickle Cell Disease (SCD)

Understanding the Menopause Transition in Sickle Cell Disease: An Interim Analysis of the Implementation of the Adapted Menopause Transition Questionnaire

Effect of the Oral LSD1 Inhibitor Ory-1001 on F-Retics in Baboons ( Papio anubis )

Translating an HPFH-Mechanism into Oral Small Molecule Therapy for Beta-Hemoglobinopathies: Clinical Proof-of-Principle

Β-Lactam Antibiotic Ceftriaxone As a Potential Therapeutic Intervention for Chronic Pain in Sickle Cell Disease

Iron Overload and Treatment Outcome in an Adult Sickle Cell Disease Cohort

Fruit and Vegetable Intake in Adults with Sickle Cell Disease

A Pilot Study for the Kidney Effects of Voxelotor in Sickle Cell Anemia

Biomarker Association with Hypertension in Mild Versus Severe Sickle Cell Disease Genotypes of a Single Center Cohort, in Comparison with African Americans from the Nhanes Study

Vaso-Occlusive Events Precipitated By Intraarticular Steroid Injections in Patients with Sickle Cell Disease

Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons

Clinical Efficacy and Safety of Erythroid Stimulating Agents in Sickle Cell Disease

A Case Series: Chiari Malformation and Sickle Cell Disease

Pain Medication: Time to First Dose in Sickle Cell Acute Care in Two Settings of a Large Urban Hospital

Clinical and Laboratory Predictors for Renal Damage in Sickle Cell Disease

A Comparison of Two Pain Assessment Tools, the Adolescent Pediatric Pain Tool and PAINReportIt and Use of the Composite Pain Index in Sickle Cell Disease

Fever In Hospitalized Adult Patients with Sickle Cell Disease

Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes

Significance of, and Difficulty in Diagnosing, Erythropoietin Deficiency in Sickle Cell Anemia

Usual Clinical Parameters Underestimate the Incidence and Significance of Erythropoietin Deficiency as a Risk Factor for Death in Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only